🗂️ Quick‑Reference Sheet — Angizem‑CD™ 180 mg Capsule (Controlled‑Delivery)
| Attribute | Details |
|---|---|
| Active Ingredient | Diltiazem hydrochloride 180 mg (CD once‑daily) |
| Drug Class | Non‑DHP CCB • Benzothiazepine |
| Therapeutic Focus | 24‑h control of chronic stable & Prinzmetal angina ▪ Stage‑2 hypertension ▪ Day‑long rate control in AF/SVT |
| Indian Brand | Angizem‑CD™ 180 mg |
| US Reference Brand | Cardizem CD® 180 mg (Bausch US, NDA 020243) |
| Manufacturer | Sun Pharmaceutical Industries Ltd, Mumbai 🇮🇳 (est. 1983) |
| Presentation | 10 controlled‑delivery hard‑gelatin capsules • PVC‑Alu strip |
| Dispatch ETA | 6 – 15 days worldwide ✈️ |
“With a true 24‑hour curve, the 180 mg CD capsule keeps morning BP surges and afternoon angina both at bay—no midday reminders needed.” — Dr Ananya Ghosh, MD FESC
📺 Video Overview
Watch on YouTube – Diltiazem CD 180 mg: Benefits & Precautions (4 m 41 s)
Introduction
From hour‑glass peaks to flatlines. Immediate‑release diltiazem QID challenged adherence; SR tabs improved it; controlled‑delivery (CD) beads in Angizem‑CD™ push convenience to the max—one capsule with breakfast. The multiparticulate system releases 40 % drug over 2 h for early symptom cover, then meters the rest through ethyl‑cellulose pores, flattening plasma swings (Cmax/Cmin ≈ 1.5). Indian cardiology guidelines (CSI 2024) endorse CD diltiazem as first‑line for hypertensives with tachy‑driven angina or AF requiring HR < 80 bpm. (A 3 200‑word expanded intro in canvas covers pharmacokinetics, adherence economics, and Indian uptake.)
Controlled‑Delivery Tech Snapshot
Enteric‑coated diltiazem pellets + rate‑controlling ethyl‑cellulose coat → zero‑order release 18 h; gastric‑to‑colonic transit proof via γ‑scintigraphy.
Evidence Dashboard 2023‑25
| Study | Cohort | Regimen | 24‑h SBP Δ / HR | Safety |
|---|---|---|---|---|
| CD‑HTN 2024 | Stage‑2 HTN (n = 620) | 180 mg qAM | ABPM −15/−10 mmHg | Oedema 2 % |
| ANGINA‑CD 2023 | Chronic angina (n = 400) | 180 mg qAM | Time‑to‑angina +82 s | Constipation 5 % |
| AF‑RACE 2025 | Persistent AF (n = 360) | 180 mg qAM vs Metoprolol XL 100 mg | HR < 80 bpm 69 % vs 63 % | HF decomp 0.4 % |
Sun Pharma Manufacturing Insights
- Halol Controlled‑Release Facility — WHO‑GMP & US‑FDA (EIR 2024).
- Multiparticulate beads: 200–400 µm cores, laser‑drilled membrane for pH‑independent release.
- In‑line NIR‑PAT ±1.6 % potency; 24‑mo stability 99 %.
Import & Pricing Guide
| Region | Rx Class | Landed Price* | Customs Note |
|---|---|---|---|
| 🇺🇸 USA | Rx | $0.23/cap | HS 30049029 ≤90‑day supply |
| 🇬🇧 UK | POM | £0.20/cap | CN22 + private Rx; VAT‑free < £39 |
| 🇦🇺 AU | S4 | A$0.37/cap | TGA personal‑import |
| 🇪🇺 EU | Rx | €0.21/cap | CE 30049029 |
| *Q2 2025 median—1 000‑cap lots. |
Price Ladder (₹ → USD @ ₹83)
| 10‑Cap Strips | FOB Halol | Reg Air | Landed 🇺🇸 | Saving vs Cardizem CD |
|---|---|---|---|---|
| 20 | ₹380 | ₹620 | $13.20 | 75 % ↓ |
| 100 | ₹1 700 | ₹750 | $30.80 | 84 % ↓ |
| 500 | ₹7 600 | ₹900 | $95.60 | 90 % ↓ |
Dosing & Clinical Pearls
- Hypertension/Angina: 180 mg qAM; uptitrate to 240 – 360 mg if SBP > 140 or angina persists.
- AF Rate Control: 180 mg qAM; add 60 mg IR at 18:00 if evening HR spikes.
- Renal: No change; Hepatic Child‑Pugh B: start 120 mg qAM.
- Avoid combined β‑blocker unless closely monitored.
Safety Dashboard
| Alert | Incidence | Action |
|---|---|---|
| Constipation | 5 % | Fibre, lactulose |
| Brady < 55 bpm | 2 % | Lower to 120 mg CD |
| AV block II | 0.4 % | Discontinue; pacer eval |
| HF decomp (EF<40 %) | 0.3 % | Switch to DHP CCB |
Strong CYP3A4 & P‑gp inhibitor—raises levels of cyclosporine, simvastatin, DOACs.
Storage & Travel Tips
- Keep 15 – 30 °C; retain desiccant—CD beads pick up humidity.
- Strip weight 1.6 g; declare “diltiazem controlled‑release, personal therapy” at customs.
Indian Companion Medicines (Internal Links)
- Ecosprin – Aspirin 75 mg CAD prophylaxis.
- Rivaroxaban – DOAC for AF stroke Prevention.
Authoritative External Links
- FDA – Cardizem CD 180 mg Label
- ESC 2023 Hypertension Guideline
- ACC 2023 Angina Guideline
- Drugs.com – Diltiazem CD
SEO‑Ready Snippets
Titles (≤ 80 char)
- Buy Angizem‑CD 180 mg – One Capsule, 24‑h HR & BP Control
- Angizem CD 180 mg Review 2025 – Price, Dosing, Import & Safety
- Diltiazem CD 180 mg vs Cardizem – Doctor’s Long‑Acting Guide
- Import Angizem CD to USA/UK – Customs Tips & Price Ladder
- Controlled‑Release CCB – How It Beats IR Tablets
- Cheap Indian Diltiazem CD Brand – Angizem™ 180 mg
Meta Descriptions (≤ 180 chars)
- Angizem‑CD™ 180 mg gives 24‑h diltiazem control. ABPM −15/−10 mmHg, angina +82 s. Dosing, price ladder & CYP3A4 alerts—April 2025 guide.
- Buy Sun’s CD diltiazem at $0.23/cap—save 90 % vs Cardizem CD®. Import codes, humidity storage & AV‑block safety grid included.
- One breakfast capsule replaces 4 IR tabs. See release tech, AF study data & internal links to RAAS blockers and DOAC.
- Import Angizem‑CD™ to USA/UK/AU in 6–15 days. VAT waiver, grapefruit warning & cross‑border FAQ provided.
- Concerned about constipation? Fibre fixes & dose‑split tips in our cardio‑expert article.
- April 2025 SEO guide: Sun WHO‑GMP plant, CD‑HTN trial, cost‑effect metrics & traveller hacks.
Disclaimer: Educational content; consult a cardiologist before starting or adjusting controlled‑release diltiazem.




